FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

PredictImmune Earns CE-IVD Mark for IBD Prognostic Test

Dec. 13, 2018
A A

UK-based prognostic tool developer PredictImmune earned the CE-IVD Mark for its PredictSURE IBD prognostic biomarker test for inflammatory bowel disease.

The accreditation followed 18 months of work to optimize the test after its transfer from University of Cambridge School of Medicine, to ensure consistency and reproducibility.

PredictSURE is “the first validated biomarker-based prognostic test” for inflammatory disease, the company says.

View today's stories